BioSpace News Archive

Invacare Corporation (“Invacare”) (NYSE: IVC) announced today the launch of the new AVIVA™ FX – MPS Maxx Multi-Position Power Standing System wheelchair, available through Motion Concepts a division of Invacare. This elegantly designed system provides maximum safety, stability and comfort whether it’s used indoors or outdoors. The AVIVA FX delivers a smooth, comfortable and stable ride with a small turning radius for in

Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today the upcoming oral presentation of data from the dose-escalation portion of the Company’s ongoing Phase 1/2 pheNIX gene therapy clinical trial with HMI-102 for adults with phenylketonuria (PKU), the world’s first PKU gene therapy clinical trial.

– New data for Genentech’s CD20xCD3 bispecific antibodies will be featured, as well as first clinical data on cevostamab, a first-of-its-kind FcRH5xCD3 bispecific antibody, in multiple myeloma – – Longer-term data for Genentech’s approved therapies in hemophilia A, chronic lymphocytic leukemia and diffuse large B-cell lymphoma reinforce the favorable efficacy and safety profile of each medicine –

Stella Diagnostics, Inc . (OTC , today announced that the Companys Chief Executive Officer, Dr. Joe Abdo was featured in an episode of the popular podcast Out of Patients with Matthew Zachary

Quansys Biosciences announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its laboratory-based IgG antibody tes

Trial participants were adults with obesity or overweight with at least one weight-related co-morbidity and without type 2 diabetes.

DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of innovative healthcare research, services and solutions to the federal government, today announced Sandra Halverson, MPH, PhD has been appointed Chief Scientist effective November 1, 2020.

The American Joint Replacement Registry (AJRR), the cornerstone of the American Academy of Orthopaedic Surgeons (AAOS) Registry Program, released its 2020 Annual Report on hip and knee arthroplasty patient outcomes

Leiters, a trusted FDA-registered 503B outsourcing provider of high-quality hospital and ophthalmology compounded sterile preparations and pharmacy services, announced that it has been awarded a 3 year agreement with Intalere.

Transgene (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces its business update for the quarter ending September 30, 2020.